» Articles » PMID: 34782334

Type 2 Diabetes and the Risk of Cardiovascular Events in Peripheral Artery Disease Versus Coronary Artery Disease

Overview
Specialty Endocrinology
Date 2021 Nov 16
PMID 34782334
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The prevalence of type 2 diabetes mellitus (T2DM) is higher in peripheral artery disease (PAD) than in coronary artery disease (CAD) patients, and PAD overall confers higher cardiovascular risk than CAD. How cardiovascular risk compares between PAD and CAD patients when analyses are stratified by the presence of type 2 diabetes is unclear and is addressed in the present study.

Research Design And Methods: We prospectively recorded major cardiovascular events (MACE; ie, cardiovascular death, myocardial infarction or stroke) over 10.0±4.7 years in 923 patients with stable CAD, of whom 26.7% had T2DM and in 292 patients with PAD, of whom 42.1% had T2DM. Four groups were analyzed: CAD patients without diabetes (CAD/T2DM-; n=677), CAD patients with T2DM (CAD/T2DM+; n=246), PAD patients without diabetes (PAD/T2DM-; n=169) and PAD patients with T2DM (PAD/T2DM+; n=123).

Results: The event rate for MACE increased over our four investigated groups: it was lowest in CAD/T2DM- patients (2.52 events per 100 person-years). It was significantly higher in CAD/T2DM+ patients (3.96 events per 100 person-years; p<0.001), in PAD/T2DM- patients (3.68 events per 100 person-years; p=0.022), and in PAD/T2DM+ patients (7.10 events per 100 person-years; p<0.001), who in turn were at a higher risk than CAD/T2DM+ or PAD/T2DM- patients (p=0.001 and p<0.001, respectively). Cox regression analysis after multivariate adjustment showed that the presence of T2DM (HR=1.44 (95% CI 1.09 to 1.92); p=0.012) and the presence of PAD versus CAD (HR=1.48 (95% CI 1.15 to 1.91); p=0.002) were mutually independent predictors of cardiovascular events.

Conclusions: In conclusion, our data show that T2DM as well as the presence of PAD versus CAD are mutually independent predictors of MACE. Patients with both PAD and T2DM are at an exceedingly high risk of cardiovascular events.

Citing Articles

Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis.

Mader A, Haeberli D, Larcher B, Dopheide J, Saely C, Heinzle C Sci Rep. 2025; 15(1):2792.

PMID: 39843486 PMC: 11754429. DOI: 10.1038/s41598-024-84985-x.


Lesion Localization and Limb Outcomes in Elderly Patients with and Without Type 2 Diabetes Mellitus Who Undergo Atherectomy-Assisted Endovascular Revascularization due to Symptomatic Peripheral Artery Disease.

Katsiki N, Geiss E, Giesen A, Jehn A, Rammos C, Karcher J J Clin Med. 2024; 13(21).

PMID: 39518525 PMC: 11546110. DOI: 10.3390/jcm13216385.


The Influence of Dapagliflozin on Foot Microcirculation in Patients with Type 2 Diabetes with and without Peripheral Arterial Disease-A Pilot Study.

Bradaric B, Bulum T, Brkljacic N, Mihaljevic Z, Benic M, Bradaric Lisic B Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338292 PMC: 11435400. DOI: 10.3390/ph17091127.


Correlation between serum 25-hydroxyvitamin D level and peripheral arterial disease in patients with type 2 diabetes mellitus: a single-center retrospective study.

Zhou C, Zhou B, Yao K, Yang J, Yan Y, Ning Y Am J Transl Res. 2024; 16(8):3759-3768.

PMID: 39262743 PMC: 11384398. DOI: 10.62347/YOBS2983.


Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.

Mahe G, Aboyans V, Cosson E, Mohammedi K, Sarlon-Bartoli G, Laneelle D Cardiovasc Diabetol. 2024; 23(1):220.

PMID: 38926722 PMC: 11210102. DOI: 10.1186/s12933-024-02325-9.


References
1.
Saely C, Aczel S, Marte T, Langer P, Drexel H . Cardiovascular complications in Type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state. Diabetologia. 2003; 47(1):145-6. DOI: 10.1007/s00125-003-1274-6. View

2.
Drexel H, Amann F, Beran J, Rentsch K, Candinas R, Muntwyler J . Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation. 1994; 90(5):2230-5. DOI: 10.1161/01.cir.90.5.2230. View

3.
Hussein A, Uno K, Wolski K, Kapadia S, Schoenhagen P, Tuzcu E . Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol. 2011; 57(10):1220-5. DOI: 10.1016/j.jacc.2010.10.034. View

4.
Low Wang C, Hess C, Hiatt W, Goldfine A . Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016; 133(24):2459-502. PMC: 4910510. DOI: 10.1161/CIRCULATIONAHA.116.022194. View

5.
Ozcan C, Deleskog A, Olsen A, Nordahl Christensen H, Hansen M, Gislason G . Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study. Eur Heart J Cardiovasc Pharmacother. 2017; 4(1):25-35. PMC: 5843132. DOI: 10.1093/ehjcvp/pvx009. View